Non-Hodgkin's Lymphoma Online Resources

There are myriad lymphoma resources on the web. This list represents what we believe to be the most comprehensive and authoritative lymphoma sites. Please contact us if you have other recommendations.

non-Hodgkin's Lymphoma at National Cancer Institute
The NCI, established under the National Cancer Institute Act of 1937, is the U.S. Federal Government's principal agency for cancer research and training.
non-Hodgkin Lymphoma at Cancer.net
The site of the American Society of Clinical Oncology (ASCO), ASCO is composed of more than 27,000 oncologists globally who are the leaders in advancing cancer care. All the information and content on Cancer.Net was developed and approved by the cancer doctors who are members of ASCO.
non-Hodgkin's Lymphoma at the Mayo Clinic
Mayo Clinic is a not-for-profit medical practice dedicated to the diagnosis and treatment of virtually every type of complex illness.
Lymphoma at MedlinePlus (NIH)
MedlinePlus brings together authoritative information from NLM, the National Institutes of Health (NIH), and other government agencies and health-related organizations. Preformulated MEDLINE searches are included in MedlinePlus and give easy access to medical journal articles. MedlinePlus also has extensive information about drugs, an illustrated medical encyclopedia, interactive patient tutorials, and latest health news.
non-Hodgkin's Lymphoma at Patient UK
Patient UK is a joint venture between PiP and EMIS (Egton Medical Information Systems). The aim of the site is to provide non-medical people in the UK with good quality information about health and disease. The authors do this by writing evidence-based information leaflets on a wide range of medical and health topics.
non-Hodgkin's Lymphoma at UCLA Health
For more than half a century, UCLA Health System has provided the best in healthcare and the latest in medical technology to the people of Los Angeles and throughout the world.
non-Hodgkin's Lymphoma at University of Texas M.D. Anderson Cancer Center
the Anderson Center offers a variety of prevention and support programs for patients, survivors and family, including language and travel services for international patients.
non-Hodgkin's Lymphoma at oncologychannel.com
Developed and monitored by board-certified physicians, oncologychannel provides comprehensive, trustworthy information about tumors, types of cancer
non-Hodgkin Lymphoma at the Merck Manual
In 1899, Merck & Co. first published a small book titled Merck's Manual of the Materia Medica. It was meant as an aid to physicians and pharmacists, reminding doctors that “Memory is treacherous.” The comprehensive Merck Manual (as it was later known) became a favorite of those involved in medical care and others in need of a medical reference.
non-Hodgkin Lymphoma at cancerbackup.org
Cancerbackup merged with Macmillan Cancer Support in April 2008. Their vision is for all people affected by cancer to have the information they want, when they want it.

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap